[A NEW OUTLOOK IN ANTIBACTERIAL THERAPEUTICS. COMBINED USE OF PROTEOLYTIC ANZYMES AND BROAD-SPECTRUM ANTIBIOTICS].
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002918:Chymotrypsin; D004358:Drug Therapy; D006801:Humans; D006867:Hydrolases; D007239:Infections; D007249:Inflammation; D010600:Pharmacology; D011500:Protein Synthesis Inhibitors; D013752:Tetracycline; D014357:Trypsin
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D011500:Protein Synthesis Inhibitors; D006867:Hydrolases; D002918:Chymotrypsin; D014357:Trypsin; D013752:Tetracycline
CHYMOTRYPSIN; DRUG THERAPY; INFECTION; INFLAMMATION; PHARMACOLOGY; TETRACYCLINE; TRYPSIN
UN NEUVO ENFOQUE A LA TERAP'EUTICA ANTIMICROBIANA. EL USE COMBINADO DE PROTEOL'ITICOS CON ANTIBI'OTICOS DE AMPLIO ESPECTRO.